Insurance Coverage Hero Image

America’s Biopharmaceutical Companies are partnering with health insurers to improve how we pay for medicines. We must ensure health plans can cover more of the newest medicines and give patients more choices – improving care and lowering health care costs for Americans.


RELATED ARTICLES

MAT Oct 31 Thumbnail

Providing Patients with Cost Information and Tools to Navigate Insurance Coverage

The biopharmaceutical industry is dedicated to finding lifesaving treatments but also making sure patients can access them.

Moving Toward a Value-Driven Health Care System image

Moving Toward a Value-Driven Health Care System

To advance a value-driven care system, we need better information, a focus on outcomes that matter to patients and flexible new approaches to paying for medicines.

Researcher Profile: David Cobden image

Researcher Profile: David Cobden

Learn about what America's biopharmaceutical companies are doing to ensure we can continue to afford innovation by reading the story of David Cobden, Ph.D., who works to pursue new payment models for a variety of cutting-edge treatments.

Innovative Medicines Deserve an Innovative Payment System image

Innovative Medicines Deserve an Innovative Payment System

Over the past several years, we've witnessed an unprecedented pace of innovation which has ushered in a new era of medicine.

World Health Day image

World Health Day: How Do We Afford the New Era of Medicine?

For World Health Day, the World Health Organization reminds us that “everyone, everywhere should be able to access essential, quality health services without facing financial hardship.”

Can We Afford the New Era of Medicine

Can We Afford the New Era of Medicine?

Innovative treatments require innovative partnerships. America's Biopharmaceutical Companies and insurers are partnering to get the right medicine in the hands of patients who need them.

Clinical Trial Provides Patient A Second Chance image

Clinical Trial Provides Patient A Second Chance

Twenty years ago, there were no effective treatments for the disease from which Marina Symcox was suffering. Learn more about the role clinical trials played in giving Marina a second chance.